Neutral
Denali CEO’s ‘greatest professional moment’ arrives as rare disease drug launches
Denali Therapeutics CEO Ryan Watts describes the FDA approval of Avlayah, a Hunter syndrome drug, as the "greatest professional moment" of his life, c...